ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 78 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $221,829 | -24.0% | 296,959 | -1.2% | 0.00% | – |
Q2 2023 | $291,748 | +8.5% | 300,463 | -2.3% | 0.00% | – |
Q1 2023 | $268,843 | -8.2% | 307,601 | +0.0% | 0.00% | – |
Q4 2022 | $292,968 | -48.5% | 307,449 | -40.6% | 0.00% | – |
Q3 2022 | $569,000 | -10.5% | 517,559 | -1.5% | 0.00% | – |
Q2 2022 | $636,000 | -81.5% | 525,556 | -67.2% | 0.00% | – |
Q1 2022 | $3,444,000 | -81.8% | 1,601,018 | +0.2% | 0.00% | – |
Q4 2021 | $18,971,000 | -1.3% | 1,598,303 | +28.9% | 0.00% | -100.0% |
Q3 2021 | $19,227,000 | -13.0% | 1,239,562 | +14.3% | 0.00% | 0.0% |
Q2 2021 | $22,099,000 | +39.7% | 1,084,044 | +55.8% | 0.00% | – |
Q1 2021 | $15,824,000 | -13.9% | 695,878 | +4.7% | 0.00% | -100.0% |
Q4 2020 | $18,376,000 | – | 664,607 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,320,381 | $1,733,325 | 0.92% |
TANG CAPITAL MANAGEMENT LLC | 3,329,048 | $2,486,799 | 0.35% |
Vivo Capital, LLC | 3,547,030 | $2,649,631 | 0.29% |
Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $555,182 | 0.22% |
Newtyn Management, LLC | 920,000 | $687,240 | 0.17% |
SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $472,020 | 0.14% |
EcoR1 Capital, LLC | 3,948,360 | $2,949,425 | 0.10% |
HHLR ADVISORS, LTD. | 2,309,764 | $1,725,394 | 0.04% |
Baker Brothers Advisors | 2,076,400 | $1,551,071 | 0.01% |
HARBOURVEST PARTNERS LLC | 18,783 | $14,031 | 0.01% |